missing translation for 'onlineSavingsMsg'
Learn More
Learn More
NCAM-1/CD56 Antibody (RNL-1), DyLight 488, Novus Biologicals™
Mouse Monoclonal Antibody
Marca: Novus Biologicals NBP1-97717G
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
NCAM-1/CD56 Monoclonal specifically detects NCAM-1/CD56 in Human, Mouse samples. It is validated for Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen.
Especificaciones
| NCAM-1/CD56 | |
| Monoclonal | |
| DyLight 488 | |
| CD56, CD56 NCAM-1, CD56 antigen, MSK39, N-CAM-1, NCAM-1, NCAMantigen recognized by monoclonal 5.1H11, neural cell adhesion molecule 1, neural cell adhesion molecule, NCAM | |
| Mouse | |
| Affinity Purified | |
| RUO | |
| Primary | |
| RNL-1 was defined as a cluster I antibody during the Second International Workshop on Small Cell Lung Cancer (SCLC) Antibodies. RNL-1 recognizes NCAM which is present in small cell lung cancer (SCLC) and lung carcinoids. | |
| Store at 4C in the dark. |
| Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen) | |
| RNL-1 | |
| Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen | |
| NCAM1 | |
| Clone RNL-1 is a mouse monoclonal IgG1 antibody derived by fusion of SP2/0-Ag14 mouse myeloma cells with spleen cells from a BALB/c mouse immunized with the small cell lung cancer cell line NCI-H82. | |
| 0.1 mL | |
| Astrocyte Markers, Cellular Markers, Cytokine Research, Cytoskeleton Markers, Growth and Development, Hematopoietic Stem Cell Markers, Immunology, Innate Immunity, Membrane Vesicle Markers, Neuronal Cell Markers, Neuronal Stem Cell Markers, Neuroscience, Stem Cell Markers | |
| 4684 | |
| Human, Mouse | |
| IgG1 |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
For Research Use Only
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido